These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 26698253)

  • 1. The association between high-sensitivity C-reactive protein concentration and diabetic nephropathy: a meta-analysis.
    Liu Q; Jiang CY; Chen BX; Zhao W; Meng D
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4558-68. PubMed ID: 26698253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [High-sensitive C-reactive protein and Type 2 diabetic nephropathy].
    Liao L; Lei MX; Chen HL; Wu J; Guo LJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):627-30. PubMed ID: 16114543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hs-CRP Is Associated With Incident Diabetic Nephropathy: Findings From the Jackson Heart Study.
    Sinha SK; Nicholas SB; Sung JH; Correa A; Rajavashisth TB; Norris KC; Lee JE
    Diabetes Care; 2019 Nov; 42(11):2083-2089. PubMed ID: 31511234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between homocysteine status and the risk of nephropathy in type 2 diabetes mellitus.
    Mao S; Xiang W; Huang S; Zhang A
    Clin Chim Acta; 2014 Apr; 431():206-10. PubMed ID: 24534450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum high-sensitivity C-reactive protein levels are associated with high risk of development, not progression, of diabetic nephropathy among Japanese type 2 diabetic patients: a prospective cohort study (Diabetes Distress and Care Registry at Tenri [DDCRT7]).
    Hayashino Y; Mashitani T; Tsujii S; Ishii H;
    Diabetes Care; 2014 Nov; 37(11):2947-52. PubMed ID: 25168126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum amyloid A and C-reactive protein levels may predict microalbuminuria and macroalbuminuria in newly diagnosed type 1 diabetic patients.
    Overgaard AJ; McGuire JN; Hovind P; Parving HH; Rossing P; Pociot F
    J Diabetes Complications; 2013; 27(1):59-63. PubMed ID: 22885250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between interleukin-19 concentration and diabetic nephropathy.
    Li L; Jiang XG; Hu JY; Yu ZQ; Xu JY; Liu F; Zhao GC; Zhang L; Gu HM; Zhang SJ; Meng J
    BMC Nephrol; 2017 Feb; 18(1):65. PubMed ID: 28201997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus.
    Mojahedi MJ; Bonakdaran S; Hami M; Sheikhian MR; Shakeri MT; Aiatollahi H
    Iran J Kidney Dis; 2009 Jan; 3(1):12-6. PubMed ID: 19377253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.
    Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Zhang Y
    Clin Chim Acta; 2017 Mar; 466():31-37. PubMed ID: 28073663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis on the relationship of eNOS 4b/a polymorphism and diabetic nephropathy susceptibility.
    Zeng R; Duan L; Sun L; Kong Y; Wu X; Wang Y; Xin G; Yang K
    Ren Fail; 2014 Nov; 36(10):1520-35. PubMed ID: 25296103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of low-grade inflammation with nephropathy in type 2 diabetic patients: role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines.
    Abrahamian H; Endler G; Exner M; Mauler H; Raith M; Endler L; Rumpold H; Gerdov M; Mannhalter C; Prager R; Irsigler K; Wagner OF
    Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):38-41. PubMed ID: 17286233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between angiotensinogen M235T polymorphisms and the risk of diabetic nephropathy: A meta-analysis.
    Zhou B; Wen M; Mi L; Hu CJ; Zhang Y; Wang JT; Tang L
    Diabetes Res Clin Pract; 2018 Aug; 142():26-36. PubMed ID: 29775675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking as a risk factor for diabetic nephropathy: a meta-analysis.
    Su S; Wang W; Sun T; Ma F; Wang Y; Li J; Xu Z
    Int Urol Nephrol; 2017 Oct; 49(10):1801-1807. PubMed ID: 28631246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of serum C-reactive protein and cartilage oligomeric matrix protein levels as biomarkers for clinical knee osteoarthritis.
    Zhang J
    BMC Musculoskelet Disord; 2018 Jan; 19(1):22. PubMed ID: 29351749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum pentraxin 3 concentrations with diabetic nephropathy.
    Wang R; Zhang J; Hu W
    J Investig Med; 2016 Aug; 64(6):1124-7. PubMed ID: 27233528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of oxidative stress and cellular inflammation in patients with diabetic nephropathy and non-diabetic nephropathy being administered hemodialysis treatment due to chronic renal failure.
    Avci E; Cakir E; Cevher SC; Yaman H; Agilli M; Bilgi C
    Ren Fail; 2014 Jun; 36(5):767-73. PubMed ID: 24579657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein and fracture risk: an updated systematic review and meta-analysis of cohort studies through the use of both frequentist and Bayesian approaches.
    Mun H; Liu B; Pham THA; Wu Q
    Osteoporos Int; 2021 Mar; 32(3):425-435. PubMed ID: 32935169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of YKL-40 in patients with diabetes mellitus: a systematic review and meta-analysis.
    Luo W; Zhang L; Sheng L; Zhang Z; Yang Z
    Diabetol Metab Syndr; 2021 Jan; 13(1):6. PubMed ID: 33446257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin Treatment for Atrial Fibrillation Reduces Serum High-Sensitivity C-Reactive Protein Levels.
    Su FC; Li XD; Sun SX; Shi MY; Xue FH; Teng SC; Jiang L; Zhu J; Yin F; Gu HY
    Biomed Res Int; 2015; 2015():402481. PubMed ID: 26229958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of the intrarenal arterial resistance index for the identification and prediction of diabetic nephropathy.
    Masulli M; Mancini M; Liuzzi R; Daniele S; Mainenti PP; Vergara E; Genovese S; Salvatore M; Vaccaro O
    Nutr Metab Cardiovasc Dis; 2009 Jun; 19(5):358-64. PubMed ID: 18805683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.